Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	28.85	-2.18	-3.06
Graham Fair Price	41.65	0.04	0.03
PEG	-59.88	0.06	-0.15
Price/Book	-4.32	0.30	0.31
Price/Cash Flow	100.00	2.88	0.00
Prices/Earnings	-52.16	5.88	12.30
Price/Sales	-52.16	2.71	5.67
Price/FCF	100.00	2.88	0.00
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-61.97	0.28	0.74
Operating Margin	-53.53	0.15	0.32
ROA	100.00	0.01	< 0.005
ROE	< 0.005	0.01	100.00
ROIC	0.02	0.02	-3.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.71	-0.51	38.31
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.61	-0.07	88.38
EPS QOQ	-0.84	1.00	19.23
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	-0.42	1.00	135.68
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.34	0.42	-82.03
Days Sales Outstanding (DSO)	28.34	39.66	39.92
Inventory Turnover	38.49	214.21	456.55
Debt/Capitalization	< 0.005	< 0.005	69.86
Quick Ratio	17.87	18.98	6.23
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.08	0.08	0.16
Cash	0.03	0.03	-0.52
Capex	0.00	< 0.005	-100.00
Free Cash Flow	0.00	< 0.005	100.00
Revenue	< 0.005	< 0.005	100.33
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	19.46	19.46	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-12.70	-8.17	35.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating